Published in Nature on October 27, 1977
Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res (2009) 7.83
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest (1998) 3.34
Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A (2003) 3.10
A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02
Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol (1991) 2.92
Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci U S A (1985) 2.50
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest (1998) 2.42
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol (2007) 2.27
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest (1996) 2.20
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med (1996) 2.14
Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med (2011) 2.13
Aging and wound healing. World J Surg (2004) 2.12
MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest (1998) 2.09
Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol (1990) 2.09
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med (1994) 2.05
Resolution of inflammation: an integrated view. EMBO Mol Med (2013) 2.01
Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes (2007) 2.01
Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res (2012) 1.94
Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol (1980) 1.87
Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci U S A (1989) 1.82
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol (1998) 1.66
Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A (1994) 1.65
Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg (1982) 1.62
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest (1986) 1.57
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci U S A (1996) 1.52
Isolation of a nonmitogenic angiogenesis factor from wound fluid. Proc Natl Acad Sci U S A (1982) 1.50
Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem (2001) 1.48
Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res (2003) 1.38
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. Proc Natl Acad Sci U S A (1980) 1.34
Macrophages promote cyst growth in polycystic kidney disease. J Am Soc Nephrol (2011) 1.34
Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection. Infect Immun (2002) 1.32
Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. Tissue Eng Part A (2009) 1.28
Macrophage activation, chronic inflammation and gastrointestinal disease. Gut (1984) 1.27
Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochem J (1979) 1.23
Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol (1984) 1.23
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
The cornea--structure and macromolecules in health and disease. A review. Am J Pathol (1977) 1.19
Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats. Am J Pathol (1990) 1.18
Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol (1992) 1.17
Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials (2010) 1.15
New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest (1984) 1.12
Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol (1989) 1.12
Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol (2015) 1.10
Wound healing: the effect of macrophage and tumour derived angiogenesis factors on skin graft vascularization. Br J Exp Pathol (1987) 1.07
The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery. Front Physiol (2013) 1.07
Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am J Pathol (1993) 1.04
Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture. Br J Cancer (1980) 1.03
Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut (2007) 1.01
Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol (1993) 1.01
The hemostatic system and angiogenesis in malignancy. Neoplasia (2001) 0.99
Cellular immunity in glomerulonephritis. Am J Pathol (1982) 0.99
Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells. J Clin Invest (1993) 0.97
Stimulation of human monocyte/macrophage-derived growth factor (MDGF) production by plasma fibronectin. Am J Pathol (1983) 0.95
Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg (1980) 0.95
Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines. Am J Pathol (2000) 0.95
Cellular events associated with inflammatory angiogenesis in the mouse cornea. Am J Pathol (1991) 0.93
Inflammatory pseudotumor of lymph nodes. Immunohistochemical evidence for its fibrohistiocytic nature. Am J Pathol (1990) 0.93
Healing of focal injury in the rat liver. Am J Pathol (1985) 0.93
Salivary gland cancer stem cells. Oral Oncol (2013) 0.92
Characterization and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest (1984) 0.90
Macrophages in collateral arteriogenesis. Front Physiol (2012) 0.90
Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1. J Neuroinflammation (2010) 0.90
Enhancement of inflammatory reactions in a non-immunological air pouch model in rats. Br J Exp Pathol (1989) 0.90
Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas. Am J Pathol (1985) 0.88
Macrophage-derived growth factor for osteoblast-like cells and chondrocytes. Proc Natl Acad Sci U S A (1984) 0.88
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care (2012) 0.88
Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.87
Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis. Tissue Eng Part B Rev (2015) 0.86
Macrophages: progress and problems. Clin Exp Immunol (1981) 0.85
Wound healing. Arch Emerg Med (1985) 0.84
Angiogenic responses elicited from chorioallantoic membrane vessels by neoplastic, preneoplastic, and normal mammary tissues from GR mice. Am J Pathol (1983) 0.84
Relationship between vitamin D deficiency and cardiovascular disease. World J Cardiol (2013) 0.83
Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3. Clin Exp Immunol (1992) 0.83
Cell-mediated pathology during murine malaria-associated nephritis. Clin Exp Immunol (1993) 0.82
Prostaglandin biosynthesis in pulmonary macrophages. Am J Pathol (1979) 0.81
Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD. Sci Rep (2015) 0.81
Extracellular hydrolytic enzymes of rabbit dermal tuberculous lesions and tuberculin reactions collected in skin chambers. Am J Pathol (1978) 0.81
Laser photocoagulation for corneal stromal vascularization. Trans Am Ophthalmol Soc (1992) 0.81
Endothelial progenitor cells as factors in neovascularization and endothelial repair. World J Cardiol (2010) 0.80
Endothelial proliferation in inflammation. II. Autoradiographic studies in x-irradiated leukopenic rats after thermal injury to the skin. Am J Pathol (1978) 0.80
In vivo imaging of physiological angiogenesis from immature to preovulatory ovarian follicles. Am J Pathol (2001) 0.80
Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. Br J Cancer (1981) 0.78
Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin. J Clin Invest (1988) 0.77
The impact of hypoxia on tumor-associated macrophages. J Clin Invest (2016) 0.77
The origin of proliferating cells in the glomerulus and Bowman's capsule in nephrotoxic serum nephritis: effects of unilateral renal irradiation. Br J Exp Pathol (1981) 0.77
Immunocytochemical features of obstructed saphenous vein coronary artery bypass grafts. J Clin Pathol (1989) 0.77
Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse. Int J Exp Pathol (1992) 0.77
Chronic allograft rejection: a fresh look. Curr Opin Organ Transplant (2015) 0.77
Cellular therapy for repair of cardiac damage after acute myocardial infarction. Int J Cell Biol (2009) 0.77
New paradigms for collateral vessel growth. Basic Res Cardiol (1993) 0.76
The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes. Life Sci (2014) 0.76
Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase. Trans Am Ophthalmol Soc (2002) 0.76
The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg (2009) 0.75
Acute inflammatory response in the subcutaneous versus periprosthethic space after incisional hernia repair: an original article. BMC Surg (2014) 0.75
The microvascular response to growth factors in the hamster cheek pouch. Basic Res Cardiol (1986) 0.75
Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease. Biomed Res Int (2016) 0.75
Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (1989) 10.70
Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A (1987) 10.43
Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest (1985) 8.70
Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol (1986) 8.22
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (1992) 7.92
Antigen-presenting function of the macrophage. Annu Rev Immunol (1984) 7.83
Culture of vascular endothelium. Prog Hemost Thromb (1976) 7.05
The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell (1997) 6.34
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33
Biological action of leptin as an angiogenic factor. Science (1998) 6.02
Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med (1984) 5.89
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A (1986) 5.83
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76
Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43
Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A (1990) 5.26
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature (1987) 5.24
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09
Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A (1982) 4.85
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem (1995) 4.77
The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol (1981) 4.72
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70
The regulatory role of macrophages in antigenic stimulation. Adv Immunol (1972) 4.69
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 4.59
The basis for the immunoregulatory role of macrophages and other accessory cells. Science (1987) 4.51
Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci U S A (1984) 4.43
Tumor dormancy in vivo by prevention of neovascularization. J Exp Med (1972) 4.34
The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng (1981) 4.27
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature (1999) 4.19
Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16
Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst (1974) 4.05
Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol (1981) 3.94
Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A (1996) 3.93
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med (1997) 3.90
Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Antigen presentation: comments on its regulation and mechanism. J Immunol (1984) 3.68
Induction and detection of a human endothelial activation antigen in vivo. J Exp Med (1986) 3.66
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol (1994) 3.50
Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev (1991) 3.49
Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. J Immunol (1980) 3.46
Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol (1984) 3.41
Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39
Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun (1993) 3.38
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol (1999) 3.15
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol (1993) 3.15
Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A (1991) 3.09
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (1987) 3.08
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (1995) 3.07
Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol (1987) 3.06
Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol (1991) 3.05
Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol (1998) 3.05
Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol (1994) 3.02
A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02
Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex. J Immunol (1979) 2.93
Persistence of immunogenicity of antigen after uptake by macrophages. J Exp Med (1968) 2.93
IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol (1992) 2.89
Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 2.89
Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A (2001) 2.89
Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science (1995) 2.88
A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet (2000) 2.80
An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb (1993) 2.77
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73
Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci U S A (1986) 2.73
The costimulatory function of antigen-presenting cells. Immunol Today (1990) 2.71
The binding of clathrin triskelions to membranes from coated vesicles. Cell (1981) 2.70
The immune response of mice to antigen in macrophages. Immunology (1968) 2.67
An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med (1972) 2.65
Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest (2001) 2.61
Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol (1985) 2.59
Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin. J Cell Biol (1978) 2.54
The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis. J Exp Med (1975) 2.54
Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54
Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51
Ligand-induced movement of lymphocyte membrane macromolecules. II. Mapping of surface moieties. J Exp Med (1972) 2.49
Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A (1993) 2.48
Antigen binding and capping by lymphocytes of genetic nonresponder mice. J Exp Med (1972) 2.46
Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest (1992) 2.45
The regulation of lymphocyte functions by the macrophage. Immunol Rev (1978) 2.43
Human vascular smooth muscle in culture. Growth and ultrastructure. Lab Invest (1975) 2.41
Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 2.40
Demonstration of a soluble mediator that induces exudates rich in Ia-positive macrophages. J Exp Med (1980) 2.38
Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest (1994) 2.35
Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem (1986) 2.33
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell (1989) 2.27